167 related articles for article (PubMed ID: 23918341)
41. Re-assessing the enhanced permeability and retention effect in peripheral arterial disease using radiolabeled long circulating nanoparticles.
England CG; Im HJ; Feng L; Chen F; Graves SA; Hernandez R; Orbay H; Xu C; Cho SY; Nickles RJ; Liu Z; Lee DS; Cai W
Biomaterials; 2016 Sep; 100():101-9. PubMed ID: 27254470
[TBL] [Abstract][Full Text] [Related]
42. MRI Study of the Influence of Surface Coating Aging on the In Vivo Biodistribution of Iron Oxide Nanoparticles.
Carregal-Romero S; Plaza-García S; Piñol R; Murillo JL; Ruiz-Cabello J; Padro D; Millán A; Ramos-Cabrer P
Biosensors (Basel); 2018 Dec; 8(4):. PubMed ID: 30545065
[TBL] [Abstract][Full Text] [Related]
43. Dual nano-sized contrast agents in PET/MRI: a systematic review.
Lahooti A; Sarkar S; Laurent S; Shanehsazzadeh S
Contrast Media Mol Imaging; 2016 Nov; 11(6):428-447. PubMed ID: 28102031
[TBL] [Abstract][Full Text] [Related]
44. Fluorescent magnetic nanoparticles with specific targeting functions for combinded targeting, optical imaging and magnetic resonance imaging.
Chen YC; Chang WH; Wang SJ; Hsieh WY
J Biomater Sci Polym Ed; 2012; 23(15):1903-22. PubMed ID: 22024467
[TBL] [Abstract][Full Text] [Related]
45. On the use of superparamagnetic hydroxyapatite nanoparticles as an agent for magnetic and nuclear in vivo imaging.
Adamiano A; Iafisco M; Sandri M; Basini M; Arosio P; Canu T; Sitia G; Esposito A; Iannotti V; Ausanio G; Fragogeorgi E; Rouchota M; Loudos G; Lascialfari A; Tampieri A
Acta Biomater; 2018 Jun; 73():458-469. PubMed ID: 29689381
[TBL] [Abstract][Full Text] [Related]
46. Magnetic iron oxide nanoparticles for multimodal imaging and therapy of cancer.
Thomas R; Park IK; Jeong YY
Int J Mol Sci; 2013 Jul; 14(8):15910-30. PubMed ID: 23912234
[TBL] [Abstract][Full Text] [Related]
47. Synthesis of 64Cu-labeled magnetic nanoparticles for multimodal imaging.
Jarrett BR; Gustafsson B; Kukis DL; Louie AY
Bioconjug Chem; 2008 Jul; 19(7):1496-504. PubMed ID: 18578485
[TBL] [Abstract][Full Text] [Related]
48. Iron oxide nanoparticle-micelles (ION-micelles) for sensitive (molecular) magnetic particle imaging and magnetic resonance imaging.
Starmans LW; Burdinski D; Haex NP; Moonen RP; Strijkers GJ; Nicolay K; Grüll H
PLoS One; 2013; 8(2):e57335. PubMed ID: 23437371
[TBL] [Abstract][Full Text] [Related]
49. Magnetic resonance imaging contrast agent: cRGD-ferric oxide nanometer particle and its role in the diagnosis of tumor.
Yi X; Ding Y; Zeng Y; Zhou C; Luo B; Meng S; Rui W; Zhao Y; Li W
J Nanosci Nanotechnol; 2011 May; 11(5):3800-7. PubMed ID: 21780371
[TBL] [Abstract][Full Text] [Related]
50. Molecular imaging of activated platelets via antibody-targeted ultra-small iron oxide nanoparticles displaying unique dual MRI contrast.
Ta HT; Li Z; Hagemeyer CE; Cowin G; Zhang S; Palasubramaniam J; Alt K; Wang X; Peter K; Whittaker AK
Biomaterials; 2017 Jul; 134():31-42. PubMed ID: 28453956
[TBL] [Abstract][Full Text] [Related]
51. Magnetic targeting combined with active targeting of dual-ligand iron oxide nanoprobes to promote the penetration depth in tumors for effective magnetic resonance imaging and hyperthermia.
Chen L; Wu Y; Wu H; Li J; Xie J; Zang F; Ma M; Gu N; Zhang Y
Acta Biomater; 2019 Sep; 96():491-504. PubMed ID: 31302299
[TBL] [Abstract][Full Text] [Related]
52. Biocompatible Peptide-Coated Ultrasmall Superparamagnetic Iron Oxide Nanoparticles for In Vivo Contrast-Enhanced Magnetic Resonance Imaging.
Chee HL; Gan CRR; Ng M; Low L; Fernig DG; Bhakoo KK; Paramelle D
ACS Nano; 2018 Jul; 12(7):6480-6491. PubMed ID: 29979569
[TBL] [Abstract][Full Text] [Related]
53. In vivo evaluation of (64)Cu-labeled magnetic nanoparticles as a dual-modality PET/MR imaging agent.
Glaus C; Rossin R; Welch MJ; Bao G
Bioconjug Chem; 2010 Apr; 21(4):715-22. PubMed ID: 20353170
[TBL] [Abstract][Full Text] [Related]
54. Functionalised iron oxide nanoparticles for multimodal optoacoustic and magnetic resonance imaging.
Bell G; Balasundaram G; Attia ABE; Mandino F; Olivo M; Parkin IP
J Mater Chem B; 2019 Apr; 7(13):2212-2219. PubMed ID: 32073580
[TBL] [Abstract][Full Text] [Related]
55. Development of Ga-68 labeled, biotinylated thiosemicarbazone dextran-coated iron oxide nanoparticles as multimodal PET/MRI probe.
Gholipour N; Akhlaghi M; Mokhtari Kheirabadi A; Geramifar P; Beiki D
Int J Biol Macromol; 2020 Apr; 148():932-941. PubMed ID: 31981670
[TBL] [Abstract][Full Text] [Related]
56. Janus Iron Oxides @ Semiconducting Polymer Nanoparticle Tracer for Cell Tracking by Magnetic Particle Imaging.
Song G; Chen M; Zhang Y; Cui L; Qu H; Zheng X; Wintermark M; Liu Z; Rao J
Nano Lett; 2018 Jan; 18(1):182-189. PubMed ID: 29232142
[TBL] [Abstract][Full Text] [Related]
57. Tumor-targeted drug delivery and MRI contrast enhancement by chlorotoxin-conjugated iron oxide nanoparticles.
Sun C; Fang C; Stephen Z; Veiseh O; Hansen S; Lee D; Ellenbogen RG; Olson J; Zhang M
Nanomedicine (Lond); 2008 Aug; 3(4):495-505. PubMed ID: 18694312
[TBL] [Abstract][Full Text] [Related]
58. The effect of mechanical properties of iron oxide nanoparticle-loaded functional nano-carrier on tumor targeting and imaging.
Choi WI; Kim JY; Heo SU; Jeong YY; Kim YH; Tae G
J Control Release; 2012 Sep; 162(2):267-75. PubMed ID: 22824783
[TBL] [Abstract][Full Text] [Related]
59. Targeted dual-contrast T1- and T2-weighted magnetic resonance imaging of tumors using multifunctional gadolinium-labeled superparamagnetic iron oxide nanoparticles.
Yang H; Zhuang Y; Sun Y; Dai A; Shi X; Wu D; Li F; Hu H; Yang S
Biomaterials; 2011 Jul; 32(20):4584-93. PubMed ID: 21458063
[TBL] [Abstract][Full Text] [Related]
60. Surface functionalization of magnetic iron oxide nanoparticles for MRI applications - effect of anchoring group and ligand exchange protocol.
Smolensky ED; Park HY; Berquó TS; Pierre VC
Contrast Media Mol Imaging; 2011; 6(4):189-99. PubMed ID: 21861279
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
